Dawn Parsell Otto, Senior VP, Clinical Development at Tricida, Inc. (TCDA), sold 665 shares at $23.27 ($15K) on 2019-01-07, disclosed to the SEC on 2019-01-08.
Scheduled sale ($15k) by Senior VP, Clinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| TCDA | SELL | 2020-04-30 | $172K | — | Filing → |
| TCDA | SELL | 2020-03-04 | $214K | — | Filing → |
| TCDA | SELL | 2020-02-05 | $242K | — | Filing → |